Medtronic Pre-Tax Profit Margin 2010-2025 | MDT
Current and historical pre-tax profit margin for Medtronic (MDT) from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Medtronic pre-tax profit margin for the three months ending April 30, 2025 was .
| Medtronic Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-04-30 | $33.54B | $5.63B | 16.78% |
| 2025-01-31 | $33.20B | $5.22B | 15.73% |
| 2024-10-31 | $33.00B | $5.16B | 15.62% |
| 2024-07-31 | $32.58B | $4.91B | 15.07% |
| 2024-04-30 | $32.36B | $4.84B | 14.95% |
| 2024-01-31 | $32.32B | $5.53B | 17.11% |
| 2023-10-31 | $31.96B | $5.43B | 17.00% |
| 2023-07-31 | $31.56B | $5.52B | 17.48% |
| 2023-04-30 | $31.23B | $5.36B | 17.18% |
| 2023-01-31 | $30.77B | $5.42B | 17.60% |
| 2022-10-31 | $30.81B | $5.63B | 18.27% |
| 2022-07-31 | $31.07B | $5.73B | 18.44% |
| 2022-04-30 | $31.69B | $5.52B | 17.41% |
| 2022-01-31 | $31.79B | $5.48B | 17.24% |
| 2021-10-31 | $31.80B | $5.11B | 16.08% |
| 2021-07-31 | $31.60B | $4.14B | 13.12% |
| 2021-04-30 | $30.12B | $3.90B | 12.93% |
| 2021-01-31 | $27.93B | $2.53B | 9.07% |
| 2020-10-31 | $27.87B | $2.89B | 10.38% |
| 2020-07-31 | $27.93B | $3.66B | 13.11% |
| 2020-04-30 | $28.91B | $4.06B | 14.02% |
| 2020-01-31 | $31.06B | $5.14B | 16.55% |
| 2019-10-31 | $30.89B | $4.93B | 15.97% |
| 2019-07-31 | $30.67B | $4.99B | 16.29% |
| 2019-04-30 | $30.56B | $5.20B | 17.01% |
| 2019-01-31 | $30.56B | $5.63B | 18.43% |
| 2018-10-31 | $30.38B | $5.29B | 17.40% |
| 2018-07-31 | $29.95B | $5.66B | 18.90% |
| 2018-04-30 | $29.95B | $5.68B | 18.95% |
| 2018-01-31 | $29.73B | $5.39B | 18.12% |
| 2017-10-31 | $29.64B | $5.33B | 17.97% |
| 2017-07-31 | $29.93B | $4.81B | 16.07% |
| 2017-04-30 | $29.71B | $4.60B | 15.49% |
| 2017-01-31 | $29.36B | $4.30B | 14.65% |
| 2016-10-31 | $29.01B | $4.51B | 15.56% |
| 2016-07-31 | $28.73B | $4.38B | 15.26% |
| 2016-04-30 | $28.83B | $4.34B | 15.04% |
| 2016-01-31 | $28.57B | $3.39B | 11.86% |
| 2015-10-31 | $25.95B | $3.40B | 13.12% |
| 2015-07-31 | $23.26B | $3.34B | 14.37% |
| 2015-04-30 | $20.26B | $3.49B | 17.21% |
| 2015-01-31 | $17.52B | $3.78B | 21.57% |
| 2014-10-31 | $17.37B | $3.54B | 20.39% |
| 2014-07-31 | $17.20B | $3.64B | 21.14% |
| 2014-04-30 | $17.01B | $3.71B | 21.79% |
| 2014-01-31 | $16.90B | $4.38B | 25.91% |
| 2013-10-31 | $16.76B | $4.58B | 27.31% |
| 2013-07-31 | $16.67B | $4.32B | 25.90% |
| 2013-04-30 | $16.59B | $4.25B | 25.62% |
| 2013-01-31 | $16.43B | $4.13B | 25.13% |
| 2012-10-31 | $16.32B | $4.03B | 24.67% |
| 2012-07-31 | $16.25B | $4.22B | 25.94% |
| 2012-04-30 | $16.18B | $4.15B | 25.61% |
| 2012-01-31 | $15.86B | $3.99B | 25.15% |
| 2011-10-31 | $15.80B | $3.93B | 24.89% |
| 2011-07-31 | $15.68B | $3.64B | 23.23% |
| 2011-04-30 | $15.51B | $3.66B | 23.63% |
| 2011-01-31 | $15.30B | $4.00B | 26.13% |
| 2010-10-31 | $15.30B | $4.07B | 26.57% |
| 2010-07-31 | $15.23B | $4.42B | 29.04% |
| 2010-04-30 | $15.39B | $3.94B | 25.62% |
| 2010-01-31 | $15.45B | $2.74B | 17.75% |
| 2009-10-31 | $15.09B | $2.57B | 17.05% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $112.441B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.616B | 27.97 |
| Boston Scientific (BSX) | United States | $153.611B | 38.46 |
| Stryker (SYK) | United States | $149.817B | 31.33 |
| EssilorLuxottica (ESLOY) | France | $128.259B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.320B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.596B | 26.03 |
| ResMed (RMD) | United States | $37.597B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.163B | 16.22 |
| Agilent Technologies (A) | United States | $33.875B | 22.08 |
| Terumo (TRUMY) | Japan | $24.770B | 32.17 |
| Koninklijke Philips (PHG) | Netherlands | $22.956B | 16.11 |
| Insulet (PODD) | United States | $21.162B | 83.07 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.315B | 11.76 |
| Baxter (BAX) | United States | $15.236B | 11.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.113B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $3.900B | 17.42 |
| Perrigo (PRGO) | Ireland | $3.676B | 9.32 |
| Haemonetics (HAE) | United States | $3.609B | 16.44 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.192B | 23.54 |
| QuidelOrtho (QDEL) | United States | $1.976B | 13.59 |
| LeMaitre Vascular (LMAT) | United States | $1.875B | 41.91 |
| AtriCure (ATRC) | United States | $1.561B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
| Phibro Animal Health (PAHC) | United States | $1.212B | 15.49 |
| Green Thumb Industries (GTBIF) | United States | $1.163B | 26.16 |
| Neogen (NEOG) | United States | $1.081B | 13.83 |
| BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
| InMode (INMD) | Israel | $0.954B | 9.62 |
| Kestra Medical Technologies (KMTS) | United States | $0.757B | 0.00 |
| Owens & Minor (OMI) | United States | $0.669B | 5.55 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
| CeriBell (CBLL) | United States | $0.622B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.507B | 0.00 |
| Valneva SE (VALN) | France | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Surmodics (SRDX) | United States | $0.424B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.344B | 12.67 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| Quanterix (QTRX) | United States | $0.315B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| ZimVie (ZIMV) | United States | $0.263B | 11.94 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Brainsway (BWAY) | Israel | $0.253B | 66.85 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 73.83 |
| Cresco Labs (CRLBF) | United States | $0.247B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.186B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.13 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 15.90 |
| Apyx Medical (APYX) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.070B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.29 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Safety Shot (SHOT) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.10 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |